慢性心力衰竭治疗的现状(5)
所有瓣膜疾病的心衰患者，均需对是否适合手术治疗作出评定。
氧气疗法[5]：与传统的观念相反，氧疗对慢性心衰患者并无应用指征。更有报告在重度心衰患者，氧疗反使血液动力学恶化。
运动[10]：以往主张限制心衰患者的运动，但长期卧床的去适应状态对患者不利。现今的观点是：应鼓励患者作动态运动。有证据表明，稳定性心衰患者，运动锻炼可提高运动耐量和生活质量，对预后的影响尚不肯定。有人认为，运动训练可作为一种新的治疗方法。
参考文献
1.Cohn JN. Struuctural changes in cardiovascular disease. Am J Cardiol, 1995,76:34-37.
2.Cohn JN. Structural basis for heart failure. Circulation, 1995,91:2504-2507
3.Katz AM. Regression of left ventricular hypertrophy: new hope for dying hearts. Circulation, 1998,98:623-624.
4.ACC/AHA Task Force Report. Guidelines for the evaluation and managerment of heart failure. JACC, 1995,26:1376-1398.
5.The task force of the working group on heart failure of the European society of cardiogy: the treatment of heart failure.Heart J, 1997,18:736-753.
6.Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1-30.
7.Dangas G, Gorlin R. The role of digitalis in the management of heart failure: old molecule new respectability. In: coats A(ed). Coutroversies in the management of heart failure. London: Churchill Livingstone, 1997.83-96.
8.Cleland JGF, McGowan J, Clark A. The evidence for β blockers in heart failure. BMJ, 1999, 318:824-825.
9.Struthers AD. Aldosterone escape during ACE inhibitor therapy in chronic heart failure. Eur Heart J, 1995,16(Suppl N):103-106
10.Clark AL. Exercise therapy in chronic heart failure-a novel management approach. In: Coats A(ed). Cotroversies in the management of heart failure. London: Churchill Livingstone,1997.157-171, http://www.100md.com(戴闺柱)
氧气疗法[5]：与传统的观念相反，氧疗对慢性心衰患者并无应用指征。更有报告在重度心衰患者，氧疗反使血液动力学恶化。
运动[10]：以往主张限制心衰患者的运动，但长期卧床的去适应状态对患者不利。现今的观点是：应鼓励患者作动态运动。有证据表明，稳定性心衰患者，运动锻炼可提高运动耐量和生活质量，对预后的影响尚不肯定。有人认为，运动训练可作为一种新的治疗方法。
参考文献
1.Cohn JN. Struuctural changes in cardiovascular disease. Am J Cardiol, 1995,76:34-37.
2.Cohn JN. Structural basis for heart failure. Circulation, 1995,91:2504-2507
3.Katz AM. Regression of left ventricular hypertrophy: new hope for dying hearts. Circulation, 1998,98:623-624.
4.ACC/AHA Task Force Report. Guidelines for the evaluation and managerment of heart failure. JACC, 1995,26:1376-1398.
5.The task force of the working group on heart failure of the European society of cardiogy: the treatment of heart failure.Heart J, 1997,18:736-753.
6.Advisory Council to Improve Outcomes Nationwide in Heart Failure. Consensus recommendations for the management of chronic heart failure. Am J Cardiol, 1999,83:1-30.
7.Dangas G, Gorlin R. The role of digitalis in the management of heart failure: old molecule new respectability. In: coats A(ed). Coutroversies in the management of heart failure. London: Churchill Livingstone, 1997.83-96.
8.Cleland JGF, McGowan J, Clark A. The evidence for β blockers in heart failure. BMJ, 1999, 318:824-825.
9.Struthers AD. Aldosterone escape during ACE inhibitor therapy in chronic heart failure. Eur Heart J, 1995,16(Suppl N):103-106
10.Clark AL. Exercise therapy in chronic heart failure-a novel management approach. In: Coats A(ed). Cotroversies in the management of heart failure. London: Churchill Livingstone,1997.157-171, http://www.100md.com(戴闺柱)